Financial Snapshot

Revenue
$24.66K
TTM
Gross Margin
Net Earnings
-$45.11M
TTM
Current Assets
$10.77M
Q2 2023
Current Liabilities
$7.565M
Q2 2023
Current Ratio
142.4%
Q2 2023
Total Assets
$28.09M
Q2 2023
Total Liabilities
$16.03M
Q2 2023
Book Value
$12.05M
Q2 2023
Cash
P/E
-0.3339
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $22.56K $2.090K $15.22M $65.91K $99.62K $119.2K $248.8K $405.7K $89.26K $90.00K $1.110M $1.510M $2.030M $9.910M $11.15M $13.28M $17.30M $18.24M $17.68M $16.45M $33.05M $24.29M $30.06M $26.74M $20.94M $6.360M $970.0K $390.0K
YoY Change 979.43% -99.99% 22999.61% -33.84% -16.41% -52.11% -38.66% 354.51% -0.82% -91.89% -26.49% -25.62% -79.52% -11.12% -16.04% -23.24% -5.15% 3.17% 7.48% -50.23% 36.06% -19.19% 12.42% 27.7% 229.25% 555.67% 148.72%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $22.56K $2.090K $15.22M $65.91K $99.62K $119.2K $248.8K $405.7K $89.26K $90.00K $1.110M $1.510M $2.030M $9.910M $11.15M $13.28M $17.30M $18.24M $17.68M $16.45M $33.05M $24.29M $30.06M $26.74M $20.94M $6.360M $970.0K $390.0K
Cost Of Revenue $2.220M $2.520M $4.090M $6.950M $5.450M $4.670M $4.750M $7.200M $7.580M $7.980M $7.110M $6.180M
Gross Profit $7.690M $8.630M $9.190M $10.35M $12.79M $13.01M $11.69M $25.85M $16.71M $22.08M $19.63M $14.76M
Gross Profit Margin 77.6% 77.4% 69.2% 59.83% 70.12% 73.59% 71.06% 78.21% 68.79% 73.45% 73.41% 70.49%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $8.583M $4.624M $7.022M $3.690M $3.786M $5.598M $7.764M $5.760M $3.844M $4.270M $2.850M $5.970M $8.710M $14.12M $14.22M $16.23M $21.20M $18.34M $15.02M $15.89M $28.14M $23.14M $34.39M $26.97M $28.29M $3.440M $140.0K $370.0K
YoY Change 85.64% -34.15% 90.3% -2.53% -32.38% -27.9% 34.79% 49.86% -9.98% 49.82% -52.26% -31.46% -38.31% -0.7% -12.38% -23.44% 15.59% 22.1% -5.48% -43.53% 21.61% -32.71% 27.51% -4.67% 722.38% 2357.14% -62.16%
% of Gross Profit 183.62% 164.77% 176.61% 204.83% 143.39% 115.45% 135.93% 108.86% 138.48% 155.75% 137.39% 191.67%
Research & Development $15.56M $20.25M $14.54M $9.494M $6.476M $9.774M $11.14M $9.894M $5.935M $2.480M $260.0K $5.400M $3.900M $8.090M $18.79M $18.81M $16.13M $12.01M $10.22M $8.260M $8.250M $7.850M $6.380M $5.930M $3.650M $0.00 $0.00 $0.00
YoY Change -23.15% 39.27% 53.16% 46.62% -33.74% -12.24% 12.56% 66.7% 139.33% 853.85% -95.19% 38.46% -51.79% -56.95% -0.11% 16.62% 34.3% 17.51% 23.73% 0.12% 5.1% 23.04% 7.59% 62.47%
% of Gross Profit 105.2% 217.73% 204.68% 155.85% 93.9% 78.55% 70.66% 31.91% 46.98% 28.89% 30.21% 24.73%
Depreciation & Amortization $575.0K $570.0K $340.0K $30.00K $80.00K $200.0K $280.0K $350.0K $980.0K $1.390M $1.630M $1.720M $1.890M $1.850M $2.300M $1.840M $1.330M $1.030M $620.0K $270.0K
YoY Change 0.87% 67.65% 1033.33% -62.5% -60.0% -28.57% -20.0% -64.29% -29.5% -14.72% -5.23% -8.99% 2.16% -19.57% 25.0% 38.35% 29.13% 66.13% 129.63%
% of Gross Profit 2.6% 3.24% 3.81% 9.47% 10.87% 12.53% 14.71% 7.31% 11.07% 10.42% 9.37% 9.01%
Operating Expenses $24.15M $24.88M $21.56M $12.20M $8.821M $12.49M $18.90M $15.65M $9.779M $6.400M $3.110M $11.40M $12.69M $22.41M $33.32M $35.56M $37.35M $30.65M $25.23M $24.16M $36.39M $30.99M $43.47M $32.89M $31.94M $13.36M $3.000M $1.360M
YoY Change -2.93% 15.36% 76.8% 38.27% -29.36% -33.93% 20.74% 60.08% 52.8% 105.79% -72.72% -10.17% -43.37% -32.74% -6.3% -4.79% 21.86% 21.48% 4.43% -33.61% 17.42% -28.71% 32.17% 2.97% 139.07% 345.33% 120.59%
Operating Profit -$14.72M -$24.69M -$26.37M -$27.00M -$17.86M -$12.22M -$12.47M -$10.54M -$14.28M -$21.39M -$13.26M -$17.18M
YoY Change -40.38% -6.37% -2.33% 51.18% 46.15% -2.0% 18.31% -26.19% -33.24% 61.31% -22.82%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense $0.00 -$163.2K -$1.809M -$890.1K -$280.00 -$40.00 -$369.4K -$1.250M -$130.0K $1.140M -$790.0K -$530.0K $910.0K -$20.00K $0.00 -$50.00K -$60.00K -$120.0K -$130.0K -$350.0K -$350.0K -$400.0K -$230.0K -$580.0K -$270.0K -$60.00K
YoY Change -100.0% -90.98% 103.19% 317785.71% 600.0% -99.99% -70.45% 861.54% -111.4% -244.3% 49.06% -158.24% -4650.0% -100.0% -16.67% -50.0% -7.69% -62.86% 0.0% -12.5% 73.91% -60.34% 114.81% 350.0%
% of Operating Profit
Other Income/Expense, Net $560.00 $10.00K $2.190K $2.260K $24.93K $8.360K $7.799M $3.665M $2.753M $0.00 $10.00K $10.00K $250.0K $0.00 $2.710M
YoY Change -94.4% 356.62% -3.1% -90.93% 198.21% -99.89% 112.78% 33.13% -100.0% 0.0% -96.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income -$20.74M -$25.02M -$8.906M -$12.77M -$10.57M -$6.345M -$10.87M -$12.15M -$7.306M -$7.570M -$1.510M -$8.740M -$10.95M -$15.24M -$23.79M -$24.77M -$24.30M -$17.91M -$12.28M -$12.58M -$10.67M -$14.63M -$21.73M -$13.66M -$17.41M -$12.58M -$2.300M -$1.030M
YoY Change -17.11% 180.88% -30.23% 20.79% 66.58% -41.63% -10.58% 66.36% -3.49% 401.32% -82.72% -20.18% -28.15% -35.94% -3.96% 1.93% 35.68% 45.85% -2.38% 17.9% -27.07% -32.67% 59.08% -21.54% 38.39% 446.96% 123.3%
Income Tax -$271.1K -$368.1K -$484.4K -$298.2K -$298.2K -$305.3K -$198.5K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$10.00K $50.00K $30.00K $20.00K $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.47M -$24.65M -$8.422M -$12.47M -$10.27M -$6.039M -$10.67M -$12.06M -$7.139M -$7.470M -$1.030M $1.310M -$6.500M -$12.35M -$18.93M -$20.26M -$19.98M -$16.22M -$11.13M -$10.94M -$10.45M -$14.65M -$21.76M -$13.68M -$17.41M -$12.58M -$2.300M -$1.030M
YoY Change -16.97% 192.66% -32.45% 21.39% 70.06% -43.4% -11.54% 68.98% -4.44% 625.24% -178.63% -120.15% -47.37% -34.76% -6.56% 1.4% 23.18% 45.73% 1.74% 4.69% -28.67% -32.67% 59.06% -21.42% 38.39% 446.96% 123.3%
Net Earnings / Revenue -90714.45% -1179321.53% -55.32% -18915.9% -10309.44% -5067.75% -4288.05% -2973.3% -7997.54% -8300.0% -92.79% 86.75% -320.2% -124.62% -169.78% -152.56% -115.49% -88.93% -62.95% -66.5% -31.62% -60.31% -72.39% -51.16% -83.14% -197.8% -237.11% -264.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.11 -$186.1K -$71.57K -$163.5K -$171.2K -$119.6K -$218.6K -$270.4K -$299.4K -$472.5K -$89.02K $126.7K -$631.1K -$1.199M -$1.843M -$2.057M -$2.030M -$1.653M -$1.139M -$1.126M -$1.085M -$1.526M -$2.519M -$1.699M -$3.017M -$3.242M -$655.3K -$343.3K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $5.241M $7.361M $27.59M $8.764M $5.434M $5.956M $14.45M $33.45M $44.37M $2.490M $8.100M $5.770M $14.13M $32.34M $34.39M $38.51M $33.51M $47.26M $58.43M $31.03M $39.94M $31.13M $28.82M $29.98M $15.39M $9.050M $3.530M
YoY Change -28.8% -73.32% 214.77% 61.29% -8.77% -58.79% -56.79% -24.6% -69.26% 40.38% -59.16% -56.31% -5.96% -10.7% 14.92% -29.09% -19.12% 88.3% -22.31% 28.3% 8.02% -3.87% 94.8% 70.06% 156.37%
Cash & Equivalents $14.45M $33.45M $44.37M
Short-Term Investments $0.00 $6.500M $7.500M $4.600M $3.000M $15.72K $1.820M $1.750M $500.0K $2.000M $4.490M $6.460M $8.450M
Other Short-Term Assets $1.632M $156.2K $1.720M $537.3K $369.6K $768.0K $758.1K $433.4K $130.0K $250.0K $460.0K $1.420M $1.440M $1.570M $1.650M $3.830M $690.0K $820.0K $870.0K $590.0K $520.0K $1.160M $1.280M
YoY Change 945.45% -90.92% 220.06% 45.38% -51.87% 1.3% 74.93% 233.35% -45.65% -67.61% -1.39% -8.28% -4.85% -56.92% 455.07% -15.85% -5.75% 47.46% 13.46% -55.17% -9.38%
Inventory $1.560M $1.330M $1.930M $3.900M $5.520M $5.490M $7.830M $6.400M $6.910M $7.520M $12.27M $9.590M $3.170M $1.010M $20.00K
Prepaid Expenses
Receivables $610.00 $0.00 $0.00 $440.00 $0.00 $1.130K $4.263M $198.9K $150.0K $0.00 $10.00K $2.420M $1.240M $1.500M $1.960M $2.320M $2.710M $2.990M $2.940M $4.440M $4.510M $5.120M $5.480M $4.970M $1.640M $30.00K $1.050M
Other Receivables $3.899M $90.98K $84.36K $1.352M $1.711M $2.534M $4.970K $4.280K $0.00 $410.0K $390.0K $3.050M $740.0K $750.0K $2.900M $1.960M $1.320M $490.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $10.77M $7.608M $29.39M $10.65M $7.514M $9.260M $19.48M $34.09M $44.65M $3.150M $8.960M $12.66M $19.12M $37.49M $42.83M $50.52M $43.75M $57.05M $70.06M $42.45M $51.87M $44.92M $47.85M $44.54M $20.19M $10.09M $4.600M
YoY Change 41.59% -74.11% 175.88% 41.78% -18.85% -52.47% -42.86% -23.65% -64.84% -29.23% -33.79% -49.0% -12.47% -15.22% 15.47% -23.31% -18.57% 65.04% -18.16% 15.47% -6.12% 7.43% 120.6% 100.1% 119.35%
Property, Plant & Equipment $0.00 $1.180K $489.6K $591.8K $90.00K $10.00K $30.00K $70.00K $170.0K $350.0K $580.0K $840.0K $4.480M $5.860M $6.730M $8.280M $9.210M $11.29M $12.66M $11.93M $8.040M $7.850M $2.560M
YoY Change -100.0% -99.76% -17.26% 557.51% -66.67% -57.14% -58.82% -51.43% -39.66% -30.95% -81.25% -23.55% -12.93% -18.72% -10.1% -18.42% -10.82% 6.12% 48.38% 2.42% 206.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $167.8K $4.335M $21.80K $12.85K $20.00K $60.00K $0.00
YoY Change -100.0% -96.13% 19787.43% 69.65% -35.75%
Other Assets $0.00 $0.00 $2.860M $4.580M $630.0K $80.00K $600.0K $4.740M $4.220M $0.00 $0.00 $6.190M $2.970M
YoY Change -100.0% -37.55% 626.98% 687.5% -86.67% -87.34% 12.32% -100.0% 108.42%
Total Long-Term Assets $17.31M $27.35M $28.70M $12.41M $13.66M $18.92M $16.43M $1.427M $1.490M $2.600M $30.00K $70.00K $170.0K $350.0K $570.0K $840.0K $7.350M $10.44M $7.350M $8.360M $10.03M $16.29M $17.17M $12.26M $8.390M $22.26M $13.91M
YoY Change -36.7% -4.69% 131.23% -9.17% -27.77% 15.13% 1051.47% -4.24% 8566.67% -57.14% -58.82% -51.43% -38.6% -32.14% -88.57% -29.6% 42.04% -12.08% -16.65% -38.43% -5.13% 40.05% 46.13% -62.31% 60.03%
Total Assets $28.09M $34.96M $58.09M $23.06M $21.18M $28.18M $35.91M $35.52M $46.14M $5.750M $8.990M $12.73M $19.29M $37.84M $43.40M $51.36M $51.10M $67.49M $77.41M $50.81M $61.90M $61.21M $65.02M $56.80M $28.58M $32.35M $18.51M
YoY Change
Accounts Payable $857.3K $1.524M $1.893M $1.694M $1.050M $1.407M $1.873M $1.300M $1.620M $81.06K $180.0K $830.0K $1.940M $2.530M $2.840M $3.430M $5.920M $5.650M $5.500M $5.960M $5.660M $4.280M $5.150M $7.730M $5.890M $2.030M $510.0K $800.0K
YoY Change -43.75% -19.49% 11.78% 61.31% -25.37% -24.87% 44.04% -19.75% 1898.52% -54.97% -78.31% -57.22% -23.32% -10.92% -17.2% -42.06% 4.78% 2.73% -7.72% 5.3% 32.24% -16.89% -33.38% 31.24% 190.15% 298.04% -36.25%
Accrued Expenses $3.472M $2.402M $3.269M $1.987M $849.9K $666.6K $155.2K $131.9K $160.0K $110.0K $1.950M $3.080M $3.430M $6.000M $3.950M $540.0K $520.0K $470.0K $360.0K $270.0K $280.0K $290.0K $290.0K $240.0K $190.0K $100.0K $50.00K
YoY Change 44.52% -26.51% 64.53% 133.77% 27.49% 329.66% 17.64% -17.58% -94.36% -36.69% -10.2% -42.83% 51.9% 631.48% 3.85% 10.64% 30.56% 33.33% -3.57% -3.45% 0.0% 20.83% 26.32% 90.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.797M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.420M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $20.00K $750.0K $840.0K $680.0K $850.0K $1.360M $1.900M $870.0K $1.130M $640.0K $390.0K
YoY Change -100.0% -97.33% -10.71% 23.53% -20.0% -37.5% -28.42% 118.39% -23.01% 76.56% 64.1%
Total Short-Term Liabilities $7.565M $4.685M $8.327M $5.067M $1.900M $3.888M $5.384M $1.432M $1.780M $81.06K $1.710M $3.870M $8.200M $5.960M $8.830M $7.380M $6.460M $6.180M $6.730M $7.170M $6.610M $5.400M $6.800M $9.920M $7.000M $3.350M $1.240M $1.260M
YoY Change 61.47% -43.73% 64.31% 166.67% -51.12% -27.8% 276.0% -19.55% 2095.9% -95.26% -55.81% -52.8% 37.58% -32.5% 19.65% 14.24% 4.53% -8.17% -6.14% 8.47% 22.41% -20.59% -31.45% 41.71% 108.96% 170.16% -1.59%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $770.0K $1.610M $2.290M $2.380M $2.290M $1.520M $2.230M $2.930M $1.910M
YoY Change -100.0% -97.4% -52.17% -29.69% -3.78% 3.93% 50.66% -31.84% -23.89% 53.4%
Other Long-Term Liabilities $6.180M $9.075M $8.981M $457.9K $1.370M $1.036M $873.9K $153.7K $0.00 $10.00K $100.0K $150.0K $240.0K $390.0K $270.0K $340.0K $250.0K $270.0K $200.0K $160.0K $120.0K $80.00K
YoY Change -31.9% 1.04% 1861.42% -66.59% 32.22% 18.61% 468.56% -100.0% -90.0% -33.33% -37.5% -38.46% 44.44% -20.59% 36.0% -7.41% 35.0% 25.0% 33.33% 50.0%
Total Long-Term Liabilities $6.180M $9.075M $8.981M $457.9K $1.370M $1.036M $873.9K $153.7K $0.00 $0.00 $10.00K $100.0K $150.0K $240.0K $390.0K $270.0K $340.0K $270.0K $1.040M $1.810M $2.450M $2.500M $2.370M $1.520M $2.230M $2.930M $1.910M
YoY Change -31.9% 1.04% 1861.42% -66.59% 32.22% 18.61% 468.56% -100.0% -90.0% -33.33% -37.5% -38.46% 44.44% -20.59% 25.93% -74.04% -42.54% -26.12% -2.0% 5.49% 55.92% -31.84% -23.89% 53.4%
Total Liabilities $16.03M $16.32M $20.24M $8.938M $6.982M $8.933M $10.57M $1.586M $1.470M $1.710M $5.510M $8.500M $8.100M $14.16M $12.71M $10.78M $8.660M $10.73M $12.56M $8.990M $8.620M $9.300M $12.29M $8.520M $5.580M $4.170M $3.170M
YoY Change -1.75% -19.35% 126.4% 28.02% -21.84% -15.51% 566.76% 7.87% -68.97% -35.18% 4.94% -42.8% 11.41% 17.9% 24.48% -19.29% -14.57% 39.71% 4.29% -7.31% -24.33% 44.25% 52.69% 33.81% 31.55%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $15.061 Million

About KAZIA THERAPEUTICS LTD

Kazia Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Sydney, New South Wales. Kazia Therapeutics Limited is an oncology focused drug development company. The firm is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.

Industry: Pharmaceutical Preparations Peers: BIONOMICS LIMITED/FI